Cigna Aktie
WKN: 866918 / ISIN: US1255091092
08.02.2016 15:52:46
|
Cigna Enters Contract With Novartis For Entresto - Quick Facts
(RTTNews) - Cigna (CI) announced it has entered into an outcomes-based contract with Novartis for Entresto, which was approved by the U.S. FDA for the treatment of heart failure with reduced ejection fraction. The agreement is effective for Cigna's commercial business.
Cigna noted that the pay-for-performance agreement ties the financial terms to how well the drug improves the relative health of Cigna's customers.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cigna Corpmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Novartis AG (Spons. ADRS)mehr Analysen
Aktien in diesem Artikel
Novartis AG (Spons. ADRS) | 98,80 | 0,61% |
|